"South America has become a new epicenter of the COVID-19 disease, certainly the most affected is Brazil at this point," Dr Mike Ryan, executive director of World Health Organization (WHO), told reporters on Friday.
"The current guidance for hydroxychloroquine does not support widespread use for COVID-19 until trials are complete," Ryan added, per Reuters, and noted that Brazil has approved wider use.
Market reaction
The USD/BRL pair largely ignored these remarks and was last seen gaining 0.2% on a daily basis at 5.5620.
Reprinted from FXStreet，the copyright all reserved by the original author.
Disclaimer: The views expressed are solely those of the author and do not represent the official position of Followme. Followme does not take responsibility for the accuracy, completeness, or reliability of the information provided and is not liable for any actions taken based on the content, unless explicitly stated in writing.
Leave Your Message Now